Polomar Health Services Inc. has announced a significant amendment to its financial agreement with Reprise Management, Inc. As part of a Second Amendment to an existing Promissory Note, the company has reduced its principal debt from $897,549.74 to $597,549.74 using proceeds from the sale of newly designated Series A Convertible Preferred Stock. The remaining balance will now be subject to a simplified annual interest rate of 12%, with the maturity date extended to July 31, 2027. Additionally, Polomar has entered into a Securities Purchase Agreement, issuing 60 shares of the preferred stock to Reprise for $300,000, which will be allocated toward paying down the principal of the Reprise Note. This strategic move aims to streamline the company's debt obligations and improve its financial structure.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。